🇺🇸 FDA
Pipeline program

Aramchol

Aramchol-020

Phase 1 small_molecule completed

Quick answer

Aramchol for NASH is a Phase 1 program (small_molecule) at Galmed Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Galmed Pharmaceuticals
Indication
NASH
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials